Your shopping cart is currently empty

Thymectacin (NB 1011) is a selective thymidine synthase (TS) inhibitor with anticancer activity for the study of colon cancer and solid tumors.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $118 | In Stock | In Stock | |
| 5 mg | $293 | In Stock | In Stock | |
| 10 mg | $475 | In Stock | In Stock | |
| 25 mg | $953 | In Stock | In Stock | |
| 50 mg | $1,530 | In Stock | In Stock | |
| 100 mg | $1,980 | In Stock | In Stock |
| Description | Thymectacin (NB 1011) is a selective thymidine synthase (TS) inhibitor with anticancer activity for the study of colon cancer and solid tumors. |
| Targets&IC50 | MDA-MB-231 cells:79 μM (EC50), PC3 cells:155 μM (EC50), HT115 cells:245 μM (EC50) |
| In vitro | The main clinical candidate, Thymectacin, showed only moderate activity in vitro, with EC50 values ranging from 79-245 μM in our assay. However, relatively minor structural adjustments resulted in a significant increase in potency.MDA-MB 231 EC50=79 μM, HT 115 EC50=245 μM, and PC-3 EC50=155 μM. [1] |
| Synonyms | NB-1011, NB1011, NB 1011 |
| Molecular Weight | 574.32 |
| Formula | C21H25BrN3O9P |
| Cas No. | 232925-18-7 |
| Smiles | O=C1N(C=C(/C=C/Br)C(=O)N1)[C@@H]2O[C@H](COP(OC3=CC=CC=C3)(N[C@H](C(OC)=O)C)=O)[C@@H](O)C2 |
| Relative Density. | 1.31g/cm3 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL(139.30 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.48 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.